Therapeutic advances in the treatment of influenza virus and possible benefits in the allergic patient

2000, Number 2

Alerg Asma Inmunol Pediatr 2000; 9 (2)

Morfín MBM

Language: Spanish
References: 5
Page: 48-49
PDF size: 201.44 Kb.

Text Extraction

No abstract

REFERENCES

Coleman PM, Varghese JN, Laver WG. Structure of the catalytic and antigenic sites in influenza virus neuraminidase. Nature 1983; 303: 41-1.
Balows A, Hausler WJ, Isenberg HD et al. Manual of Clinical Microbiology. American Society for Microbiol 1991: 868-903.
Morfín BM, López GT, Navarrete NCh et al. Early viral identification in children with asthma, rhinitis and airway hyperreactivity. Abstract #91. Ann Allergy Asthma Immunol 1998; 80: 122.
Busse WW. The role of respiratory infections in asthma. In: From genetics to quality of life. XVth World Congress of Asthmology, Montpellier. Hogrefe& Huber Publishers 1996; 99-101.
Akaike T, Maeda H, Maruo K, Sakata Y y cols. Potenciación de la infectividad y patogenia del virus de influenza A por una proteasa del ácaro del polvo casero. J Infect Dis 1994; 170: 1023-6.